A randomized, controlled trial of the toxin-blocking effects of B subunit in family members of patients with cholera

R. I. Glass, J. Holmgren, M. R. Khan, K. M. Hossain, M. I. Huq, William Greenough

Research output: Contribution to journalArticle

Abstract

A randomized, controlled field trial was performed to test the ability of B subunit, the nontoxic, binding portion of cholera toxin, to block the toxin receptors (G(M1) ganglioside) in the small intestine and thereby prevent diarrhea in individuals infected with Vibrio cholerae O1. Of 1,922 family contacts of 370 index patients selected randomly to receive orally on two successive days either B subunit (low dose, 1.0 mg; high dose, 5.0 mg) or placebo, 190 were asymptomatically infected on day 1 or day 2 of the study and within 24 h ots receiving B subunit. During the first 24-hr period of follow-up, the relative risk of disease among contact receiving B subunit versus placebo was 0.18 for the low dose (P = .08) and 0.50 for the high dose (P = .22). Subsequently the relative risk increased toward 1.0 and was at no single point significantly reduced, although in five of the six follow-up periods the risk of disease was less in the B subunit group.

Original languageEnglish (US)
Pages (from-to)495-500
Number of pages6
JournalJournal of Infectious Diseases
Volume149
Issue number4
StatePublished - 1984
Externally publishedYes

Fingerprint

Cholera
Randomized Controlled Trials
Placebos
Vibrio cholerae O1
G(M1) Ganglioside
Aptitude
Cholera Toxin
Small Intestine
Diarrhea

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

A randomized, controlled trial of the toxin-blocking effects of B subunit in family members of patients with cholera. / Glass, R. I.; Holmgren, J.; Khan, M. R.; Hossain, K. M.; Huq, M. I.; Greenough, William.

In: Journal of Infectious Diseases, Vol. 149, No. 4, 1984, p. 495-500.

Research output: Contribution to journalArticle

Glass, R. I. ; Holmgren, J. ; Khan, M. R. ; Hossain, K. M. ; Huq, M. I. ; Greenough, William. / A randomized, controlled trial of the toxin-blocking effects of B subunit in family members of patients with cholera. In: Journal of Infectious Diseases. 1984 ; Vol. 149, No. 4. pp. 495-500.
@article{4fc4d5ca58254d189e3391cd1c59a402,
title = "A randomized, controlled trial of the toxin-blocking effects of B subunit in family members of patients with cholera",
abstract = "A randomized, controlled field trial was performed to test the ability of B subunit, the nontoxic, binding portion of cholera toxin, to block the toxin receptors (G(M1) ganglioside) in the small intestine and thereby prevent diarrhea in individuals infected with Vibrio cholerae O1. Of 1,922 family contacts of 370 index patients selected randomly to receive orally on two successive days either B subunit (low dose, 1.0 mg; high dose, 5.0 mg) or placebo, 190 were asymptomatically infected on day 1 or day 2 of the study and within 24 h ots receiving B subunit. During the first 24-hr period of follow-up, the relative risk of disease among contact receiving B subunit versus placebo was 0.18 for the low dose (P = .08) and 0.50 for the high dose (P = .22). Subsequently the relative risk increased toward 1.0 and was at no single point significantly reduced, although in five of the six follow-up periods the risk of disease was less in the B subunit group.",
author = "Glass, {R. I.} and J. Holmgren and Khan, {M. R.} and Hossain, {K. M.} and Huq, {M. I.} and William Greenough",
year = "1984",
language = "English (US)",
volume = "149",
pages = "495--500",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - A randomized, controlled trial of the toxin-blocking effects of B subunit in family members of patients with cholera

AU - Glass, R. I.

AU - Holmgren, J.

AU - Khan, M. R.

AU - Hossain, K. M.

AU - Huq, M. I.

AU - Greenough, William

PY - 1984

Y1 - 1984

N2 - A randomized, controlled field trial was performed to test the ability of B subunit, the nontoxic, binding portion of cholera toxin, to block the toxin receptors (G(M1) ganglioside) in the small intestine and thereby prevent diarrhea in individuals infected with Vibrio cholerae O1. Of 1,922 family contacts of 370 index patients selected randomly to receive orally on two successive days either B subunit (low dose, 1.0 mg; high dose, 5.0 mg) or placebo, 190 were asymptomatically infected on day 1 or day 2 of the study and within 24 h ots receiving B subunit. During the first 24-hr period of follow-up, the relative risk of disease among contact receiving B subunit versus placebo was 0.18 for the low dose (P = .08) and 0.50 for the high dose (P = .22). Subsequently the relative risk increased toward 1.0 and was at no single point significantly reduced, although in five of the six follow-up periods the risk of disease was less in the B subunit group.

AB - A randomized, controlled field trial was performed to test the ability of B subunit, the nontoxic, binding portion of cholera toxin, to block the toxin receptors (G(M1) ganglioside) in the small intestine and thereby prevent diarrhea in individuals infected with Vibrio cholerae O1. Of 1,922 family contacts of 370 index patients selected randomly to receive orally on two successive days either B subunit (low dose, 1.0 mg; high dose, 5.0 mg) or placebo, 190 were asymptomatically infected on day 1 or day 2 of the study and within 24 h ots receiving B subunit. During the first 24-hr period of follow-up, the relative risk of disease among contact receiving B subunit versus placebo was 0.18 for the low dose (P = .08) and 0.50 for the high dose (P = .22). Subsequently the relative risk increased toward 1.0 and was at no single point significantly reduced, although in five of the six follow-up periods the risk of disease was less in the B subunit group.

UR - http://www.scopus.com/inward/record.url?scp=0021364921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021364921&partnerID=8YFLogxK

M3 - Article

C2 - 6373961

AN - SCOPUS:0021364921

VL - 149

SP - 495

EP - 500

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -